Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for Primary Sjogren's Disease
28 locations incl. Chandler
Sponsor: Vor Biopharma
Sex: All·Age: 18 - 75
Code: NCT07404865·Phase 3·Recruiting·Listed Feb 2026
Clinical research site in Euless, Texas
Part of Precision Comprehensive Clinical Research Solutions
As of July 2026, 2 paid clinical trials are recruiting at Precision Comprehensive Clinical Research Solutions in Euless, Texas. Active studies at this site cover conditions such as Primary Sjogren's Disease and Systemic Lupus Erythematosus. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .